• Users Online: 42486
  • Home
  • Print this page
  • Email this page

   Table of Contents      
ORIGINAL ARTICLE
Year : 2007  |  Volume : 55  |  Issue : 2  |  Page : 109-112

A clinicopathological study of eyelid malignancies from central India


1 Department of Plastic and Maxillofacial Surgery, Government Medical College, Nagpur, India
2 University of North Texas Health Science Center, Fort Worth, Texas, USA ; Lata Medical Research Foundation, Nagpur, India
3 Lata Medical Research Foundation, Nagpur, India

Date of Submission01-May-2006
Date of Acceptance20-Jul-2006

Correspondence Address:
Manju Mamtani
7458 Louis Pasteur Drive Apt #1205, San Antonio, TX - 78229, U.S.A

Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0301-4738.30703

Rights and Permissions
  Abstract 

Background: Eyelid malignancies are completely treatable if detected early. The treatment depends on the invasiveness of the cancer which in turn depends on the type of malignancy.
Aim: The aim of the study was to characterize the distribution of the types of eyelid malignancies in central India.
Settings and Design: The study was conducted in the Department of Plastic and Maxillofacial Surgery at a tertiary care hospital.
Materials and Methods: We report a series of 27 cases of eyelid malignancies. In the same case series, we also include a case of malignant hemangiopericytoma which is an extremely rare form of eyelid malignancy worldwide.
Statistical Analysis: Depending on the underlying statistical distribution, either analysis of variance (ANOVA) or the Kruskal-Wallis (K-W) test was used to assess the differential distribution of these variables across the types of eyelid malignancies observed in this study.
Results:
We observed that sebaceous cell carcinoma (~37%) was almost as prevalent as basal cell carcinoma (~44%) in the study subjects and had an earlier age of occurrence and a more rapid clinical course.
Conclusions: Sebaceous cell carcinoma of the eyelid is almost as common as basal cell carcinoma in a large tertiary care centre in central India.

Keywords: Cancer, eyelid, hemangiopericytoma.


How to cite this article:
Jahagirdar SS, Thakre TP, Kale SM, Kulkarni H, Mamtani M. A clinicopathological study of eyelid malignancies from central India. Indian J Ophthalmol 2007;55:109-12

How to cite this URL:
Jahagirdar SS, Thakre TP, Kale SM, Kulkarni H, Mamtani M. A clinicopathological study of eyelid malignancies from central India. Indian J Ophthalmol [serial online] 2007 [cited 2024 Mar 29];55:109-12. Available from: https://journals.lww.com/ijo/pages/default.aspx/text.asp?2007/55/2/109/30703

Clinical and histopathological characteristics of study subjects

Click here to view
Clinical and histopathological characteristics of study subjects

Click here to view
Although the incidence of eyelid malignancies is increasing,[1],[2],[3],[4],[5] their global distribution is varied and remains under-characterized. It is reported, for example, that 90% of the malignant eyelid tumors are basal cell carcinomas (BCC) while other malignant forms like sebaceous cell carcinoma (SbCC) and squamous cell carcinoma (SqCC) are rare.[3],[4],[6] However, case series reported from Asian countries have shown a generally higher prevalence of SbCC.[1],[2],[4],[5],[7] It is still unclear whether this increased prevalence of SbCC reflects a higher incidence of SbCC, a lower incidence of BCC or differential survival rates associated with these tumors that eventually favor a relative accumulation of SbCC in Asian populations. The aim of the study was to review our experience with a series of 27 eyelid malignancies including one case of an extremely rare form of malignant eyelid neoplasm - hemangiopericytoma (HMP).[8],[9]


  Materials and Methods Top


The present case series includes all consecutive cases of eyelid malignancies that reported to the Department of Plastic and Maxillofacial Surgery at a tertiary health care facility in central India. We included cases that reported to the study center over a six-year period starting from January 1996. During this study period, a total of 27 cases of eyelid malignancies were identified. In each case, the clinical diagnosis of eyelid malignancy was confirmed by fine needle aspiration biopsy and histopathology. The cases were treated with wide local excision with a 5-10 mm margin of normal tissue and an appropriate combination of split skin grafts (SSG), tarso-conjunctival flaps (TCF) and Mustarde's flaps (MF). Depending on the underlying statistical distribution of the continuous variables, we used analysis of variance (ANOVA) or the Kruskal-Wallis (K-W) test to assess the differential distribution of these variables across the types of eyelid malignancies observed in this study. Statistical significance was tested at an a of 0.05.


  Results Top


In our case series we encountered four types of eyelid malignancies - BCC (12 cases, 44.5%), SbCC (10 cases, 37.0%), SqCC (4 cases, 14.8%) and HMP (1 case, 3.7%). All the tumors were newly detected without a past history of irradiation. Characteristics of the study subjects are described in detail in [Table - 1]. Using ANOVA we observed that the age of the study subjects at the time of detection of the cancer was statistically significantly different across the type of malignancy (F = 3.04, P = 0.049) with SqCC cases representing the youngest age group. In all cases, the earliest manifestation was tumor. As the duration of this symptom did not follow normal distribution, we used the K-W test to assess whether it was significantly influenced by the type of malignancy. We observed that it indeed was (K-W P = 0.003).

The size of the tumor at the time of diagnosis did not vary by type of malignancy (F = 0.61, P = 0.612). We thus obtained an estimate of the rate of tumor growth (derived by dividing the size of the tumor at the time of diagnosis by the duration of symptoms). We observed that the rate of tumor growth was strongly associated with the type of malignancy (K-W P = 0.001) - BCC being the slowest growing tumor and SqCC the fastest. [Figure - 1][Figure - 2] show the representative photomicrographs of the histopathological characteristics of the four types of malignancies observed in our case series. Our case series included 18 (66.67%) females, 15 (55.6%) lower eyelid lesions and 14 (51.9%) right eye lesions.

We make a special mention of the 60-year-old female patient in T3M0N0 stage malignant hemangiopericytoma - an extremely rare form of eyelid malignancy. This patient had a very rapid-growing painful tumor of the left upper eyelid that attained a diameter of 3 cm within two months and developed ulceration. The tumor was associated with a serous discharge and was fixed to the skin but not to deeper structures. There was no itching, restriction of movement, vision problem or eyelash alopecia. This case was treated successfully with wide local excision and split skin graft.

Of the 27 study subjects, one patient refused reconstructive surgery. All 26 operated cases of malignant neoplasms underwent wide local excision. Of these, 11 resulted in partial thickness defects and 15 in full thickness defects. The most common oculoplastic procedure required was SSG alone (nine cases), TCF alone (two cases), SSG followed by TCF (13 cases) and TCF followed by MF (two cases). Postoperatively, it was observed that all the SSGs were taken up successfully. There were only two common postoperative complaints - foreign body sensation and conjunctival congestion. In addition, one subject each developed hematoma and seroma. On follow-up, 10 patients reported itching at the graft site which abated after use of topical Vaseline and oral antihistaminics. Three cases reported epiphora which subsided spontaneously. Closure and blinking of eyes were normal in all patients who completed follow-up.


  Discussion Top


Our results provide further evidence in favor of a higher proportion (30-40%) of SbCC in India. In countries like the USA and Australia, the prevalence of this condition is reported to be 1.5% and 3.8%, respectively. If, as argued,[10] the increased proportion of SbCC in China and India were to merely reflect a decreased incidence of BCC, then one would expect a proportionate increase in both SbCC and SqCC. This expectation can be explained mathematically as follows: Let us assume that a closed population of n subjects had x cases of BCC, y cases of SbCC and z cases of SqCC. Then the proportion of eyelid malignancies with BCC, SbCC and SqCC will be x/(x+y+z), y/(x+y+z) and z/(x+y+z), respectively. If over time the prevalence of only BCC was to decrease (say by a factor r, where r>1) and the population size is still n, then the new number of cases of BCC, SbCC and SqCC will be x/r (ensuring that x/r < x), y and z. Then, the proportion of eyelid malignances with SbCC and SqCC will be y/[(x/r)+y+z] and z/[(x/r)+y+z], respectively. If we compare the previous proportion of these two types of malignancies with their respective new prevalence, then we can mathematically express the change in the prevalence of SbCC as well as SqCC is a function of the original BCC proportion and the factor by which the prevalence of BCC has fallen [Figure - 3]. Since an assumption of a decreased number of BCC cases is unlikely to alter the values of y and z, it is clear that the inflation in the proportion of both SbCC and SqCC will be quantitatively similar i.e. by a factor of 1/[(x/r)+y+z]. However, three Indian studies, including the present one, as well as one study each from Japan and Taiwan demonstrate that it is the SbCC that is preferentially enriched in Asian populations.[1],[7] Thus, we reemphasize that SbCC should be actively searched for in cases of eyelid malignancies in Asia. We acknowledge a potential limitation in our method of estimation of the rate of tumor growth, which can be strongly influenced by the patient's ability to detect the first appearance of the tumor. However, it seems less likely that this ability will be differential across the type of malignancy. Therefore, given the earlier mean age at occurrence and an estimated faster rate of tumor growth, SbCC and SqCC may deserve a more aggressive treatment protocol.


  Conclusion Top


The present case series points towards the need to realize the different prevalence rates, the age distribution and rate of growth of different forms of eyelid malignancies and the attendant need for a careful search for early detection of malignancies such as SbCC and SqCC.


  Acknowledgments Top


We thank Dr. S. K. Bobhate, Professor and Head, Department of Pathology, Government Medical College and Hospital, Nagpur, India for expert histopathological diagnoses and for providing the photomicrographs.

 
  References Top

1.
Abdi UN, Tyagi V, Maheshwari V, Gogi R, Tyagi SP. Tumors of eyelid: A clinicopathologic study. J Indian Med Assoc 1996;94:405-9,416,418.  Back to cited text no. 1
    
2.
Abe MY, Ohnishi Y, Hara Y, Shinoda Y, Jingu K. Malignant tumor of the eyelid-Clinical survey during 22-year period. Jpn J Ophthalmol 1983;27:175-84.  Back to cited text no. 2
    
3.
Al-Buloushi A, Filho JP, Cassie A, Arthurs B, Burnier MN Jr. Basal cell carcinoma of the eyelid in children: A report of three cases. Eye 2005;19:1313-4.  Back to cited text no. 3
[PUBMED]  [FULLTEXT]  
4.
Shields JA, Demirci H, Marr BP, Eagle RC Jr, Shields CL. Sebaceous carcinoma of the eyelids: Personal experience with 60 cases. Ophthalmology 2004;111:2151-7.  Back to cited text no. 4
[PUBMED]  [FULLTEXT]  
5.
Wang JK, Liao SL, Jou JR, Lai PC, Kao SC, Hou PK, et al . Malignant eyelid tumors in Taiwan. Eye 2003;17:216-20.  Back to cited text no. 5
    
6.
Ni C, Searl SS, Kuo PK, Chu FR, Chong CS, Albert DM. Sebaceous cell carcinomas of the ocular adnexa. Int Ophthalmol Clin 1982;22:23-61.  Back to cited text no. 6
[PUBMED]    
7.
Sihota RK, Tandon SM, Betharia SM, Arora R. Malignant eyelid tumors in an Indian population. Arch Ophthalmol 1996;114:108-9.  Back to cited text no. 7
    
8.
Oshida N, Hisatomi U, Takemura M, Kobayashi Y. A haemangiopericytoma of the eye lid. Nippon Ganka Kiyo 1970;21:269-72.  Back to cited text no. 8
[PUBMED]    
9.
Macoul KL. Haemangiopericytoma of the lid and orbit. Am J Ophthalmol 1968;66:731-3.  Back to cited text no. 9
[PUBMED]    
10.
Levin GM. Sebaceous carcinoma of the eyelids. Ophthalmology 2005;112:2242.  Back to cited text no. 10
[PUBMED]  [FULLTEXT]  


    Figures

  [Figure - 1], [Figure - 2], [Figure - 3]
 
 
    Tables

  [Table - 1]


This article has been cited by
1 Göz Kapaklarinin Primer Kötü Huylu Tümörlerinin Klinik ve Histopatolojik Özellikleri
Çagri MUTAF, Ali SIMSEK
Harran Üniversitesi Tip Fakültesi Dergisi. 2023; : 74
[Pubmed] | [DOI]
2 A clinical study on prevalence and management of eyelid tumours – A prospective observational study
Niranjan Karthik Senthil Kumar, Malarvizhi R, Anuradha A, Latha KST
IP International Journal of Ocular Oncology and Oculoplasty. 2022; 8(1): 56
[Pubmed] | [DOI]
3 Clinicopathological Analysis and Surgical Outcome of Eyelid Malignancies: A Study of 332 Cases
Syeed Mehbub Ul Kadir, Mukti Rani Mitra, Riffat Rashid, Murtuza Nuruddin, Md. Kamrul Hassan Khan, Golam Haider, Mst. Sayedatun Nessa, Arash Kimyai Asadi
Journal of Skin Cancer. 2022; 2022: 1
[Pubmed] | [DOI]
4 An unusual presentation of well-differentiated squamous cell carcinoma of left upper eyelid: Case report
Rajneel Bhattacharjee, Baby Deka, Namrata Shree
IP International Journal of Ocular Oncology and Oculoplasty. 2021; 7(2): 217
[Pubmed] | [DOI]
5 Spectrum of eyelid lesions-a histopathological study in South India
Suguna VENUGOPAL, Aparna MURALIDHAR
Journal of Health Sciences and Medicine. 2021; 4(1): 13
[Pubmed] | [DOI]
6 Whole-exome sequencing for ocular adnexal sebaceous carcinoma suggests PCDH15 as a novel mutation associated with metastasis
Shiqiong Xu, Tyler J. Moss, Maria Laura Rubin, Jing Ning, Karina Eterovic, Hong Yu, Renbing Jia, Xianqun Fan, Michael T. Tetzlaff, Bita Esmaeli
Modern Pathology. 2020; 33(7): 1256
[Pubmed] | [DOI]
7 Programmed death receptor Ligand 1 expression in eyelid sebaceous carcinoma: a consecutive case series of 41 patients
Shiqiong Xu, Hong Yu, Guohui Fu, Xianqun Fan, Renbing Jia
Acta Ophthalmologica. 2019; 97(3)
[Pubmed] | [DOI]
8 RETROSPECTIVE ANALYSIS OF MALIGNANT EYELID TUMOURS IN A TERTIARY CARE CENTRE– 10 YEARS SURVEY
Hemalatha Krishnamurthy, Shashidhar H B, Satish K, Manjula Devi N, Jayashree Krishnamurthy, Mohammed Abdul Kayoom N, Gajaraj Nayak, Reshma Angadi
Journal of Evolution of Medical and Dental Sciences. 2018; 7(06): 708
[Pubmed] | [DOI]
9 A STUDY ON EYELID AND CONJUNCTIVAL NEOPLASM IN A TERTIARY CARE CENTRE IN EASTERN INDIA
Soumya Swarup Chattopadhyay, Soumyadeep Majumdar, Raghuraj S. Hegde
Journal of Evidence Based Medicine and Healthcare. 2017; 4(74): 4391
[Pubmed] | [DOI]
10 SQUAMOUS CELL CARCINOMA OF EYELID MASQUERADING AS BASAL CELL CARCINOMA
Nagaraju G, Chinmayee J T, Natarajan M, Vanitha M D
Journal of Evidence Based Medicine and Healthcare. 2015; 2(16): 2456
[Pubmed] | [DOI]
11 Profile of Ocular and Adnexal Tumours at a Tertiary Institute of Northeast India
Dipankar Das,Panna Deka,Varsha Ramachandra,Kasturi Bhattacharjee,Jayanta Kumar Das,Ganesh Chandra Kuri,Prerana S. Tahiliani,Pankaj Bhattacharyya,Harsha Bhattacharjee,Rajashree Paul,Apurba Deka
Orbit. 2014; : 1
[Pubmed] | [DOI]
12 Sebaceous carcinoma in Japanese patients: clinical presentation, staging and outcomes
A. Watanabe,M. T. Sun,A. Pirbhai,K. Ueda,N. Katori,D. Selva
British Journal of Ophthalmology. 2013; 97(11): 1459
[Pubmed] | [DOI]
13 Eyelid Sebaceous Carcinoma: Clinicopathologic and Multiparametric Immunohistochemical Analysis That Includes Adipophilin
Frederick A. Jakobiec,Pia R. Mendoza
American Journal of Ophthalmology. 2013;
[Pubmed] | [DOI]
14 Tumeurs palpébrales : aspects cliniques, diagnostiques et thérapeutiques
J. Lasudry,J.-P. Adenis,P.-Y. Robert
EMC - Ophtalmologie. 2011; 8(2): 1
[Pubmed] | [DOI]
15 Eyelid tumors: Histopathological and clinical study performed in county hospital of oradea between 2000-2007
Coroi, M.-C., Roşca, E., Muţiu, G., Coroi, T., Bonta, M.
Romanian Journal of Morphology and Embryology. 2010; 51(1): 111-115
[Pubmed]
16 Clinicopathologic study of malignant eyelid tumours : Malignant eyelid tumours
Rajendra Kumar
Clinical and Experimental Optometry. 2010; 93(4): 224
[VIEW] | [DOI]
17 Intracranial extension of meibomian gland carcinoma with pagetoid changes
Yasuhiko Hayashi,Hiroshi Shima,Daisuke Kita,Masashi Kinoshita,Yuya Yoshida,Mitsuhiro Hasegawa,Jun-ichiro Hamada
Journal of Clinical Neuroscience. 2009; 16(4): 568
[Pubmed] | [DOI]
18 Intracranial extension of meibomian gland carcinoma with pagetoid changes
Hayashi, Y. and Shima, H. and Kita, D. and Kinoshita, M. and Yoshida, Y. and Hasegawa, M. and Hamada, J.
Journal of Clinical Neuroscience. 2009; 16(4): 568-570
[Pubmed]
19 Sebaceous carcinoma of the eyelids: Thirty cases from Japan
Izumi, M. and Mukai, K. and Nagai, T. and Matsubayashi, J. and Iwaya, K. and Chiu, C.S. and Goto, H.
Pathology International. 2008; 58(8): 483-488
[Pubmed]
20 Sebaceous carcinoma of the eyelids: Thirty cases from Japan
Miki Izumi,Kiyoshi Mukai,Takeshi Nagai,Jun Matsubayashi,Keiichi Iwaya,Cheng-Sheng Chiu,Hiroshi Goto
Pathology International. 2008; 58(8): 483
[Pubmed] | [DOI]



 

Top
 
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
Abstract
Materials and Me...
Results
Discussion
Conclusion
Acknowledgments
References
Article Figures
Article Tables

 Article Access Statistics
    Viewed6247    
    Printed182    
    Emailed6    
    PDF Downloaded665    
    Comments [Add]    
    Cited by others 20    

Recommend this journal